colorectal cancer

February 2, 2021 · Brielle Gregory Collins, ASCO staff
ASCO’s 2021 Advance of the Year highlights how progress in the treatment of gastrointestinal (GI) cancers is driven by molecular testing of tumors. Read More >>
December 16, 2020 · Dan Shockley
In this post, Dan Shockley discusses how his experience in the United States Navy helped shape his mindset and prepared him to keep a positive outlook throughout the diagnosis and treatment of his hereditary colon cancer condition. Read More >>
ASCO20 Virtual Scientific Program; Research Round Up Podcast Series
June 23, 2020 · Claire Smith, ASCO staff
In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program. Read More >>
ASCO20 Virtual Scientific Program: #ASCO20
May 28, 2020 · Brielle Gregory, ASCO staff
Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer. Read More >>
ASCO20 Virtual Scientific Program: #ASCO20
May 28, 2020 · Brielle Gregory, ASCO staff
Lea los puntos destacados de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Incluyen estudios sobre inmunoterapia para el cáncer colorrectal metastásico y la enfermedad trofoblástica gestacional, terapia de mantenimiento para el cáncer de vejiga avanzado, el potencial de la medicina de precisión para el cáncer infantil y la terapia dirigida después de la cirugía por EGFR (receptor del factor de crecimiento epidérmico), positivo de cáncer de pulmón de células no pequeñas. Read More >>

Pages